We welcome Prof. Ralf Weiskirchen from RWTH University Hospital Aachen, Germany, to join the Editorial Board of OBM Hepatology and Gastroenterology. Prof. Weiskirchen is currently Head of the Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC) at the RWTH University Hospital Aachen, Germany. His major focus is the analysis of TGF/BMP and PDGF signalling pathway in the pathogenesis of various diseases. Professor Weiskirchen maintains a variety of national and international cooperation’s that are focussed on molecular aspects of disease formation and therapy. Moreover, his work is focussed on the identification and evaluation of novel biomarkers. His research interests are TGF, PDGF, BMPs, gene therapy, biomarkers. We are grateful to Prof. Weiskirchen for her participation and support.